Intensifying Insulin Therapy for Patients with Hyperglycemia

Introduction to Insulin Intensification

The American Diabetes Association recommends increasing Lantus by 10-15 units (to 32-37 units nightly) and adding prandial Humalog coverage before the largest meal, starting at 4 units, while discontinuing glyburide to reduce hypoglycemia risk in patients with severe treatment failure, as indicated by an HbA1c of 10.1% with fasting glucose of 150 mg/dL despite triple therapy 1, 2

Patients with an HbA1c of 10.1% and fasting glucose of 150 mg/dL, despite being on triple therapy, require immediate action, with the current Lantus dose of 22 units being grossly inadequate, representing approximately 0.3 units/kg/day for an average-weight adult, well below the 0.5-1.0 units/kg/day typically needed for adequate basal coverage 1, 2, 3

Increase Lantus by 4 units every 3 days until fasting glucose consistently reaches 80-130 mg/dL, given that current fasting glucose is ≥140 mg/dL, with the goal of reaching approximately 0.5 units/kg/day 2, 3
For fasting glucose ≥180 mg/dL, increase by 4 units every 3 days; for 140-179 mg/dL, increase by 2 units every 3 days, to optimize basal insulin coverage 2
The current Humalog dose of 8 units TID should be increased by 1-2 units or 10-15% twice weekly based on 2-hour postprandial glucose readings, to address postprandial hyperglycemia 2

Glyburide must be stopped immediately, as the combination of sulfonylureas with complex insulin regimens significantly increases hypoglycemia risk without meaningful glycemic benefit, according to the American College of Clinical Endocrinologists 1, 2

Consider adding a GLP-1 receptor agonist, such as semaglutide or dulaglutide, to the regimen, which can provide HbA1c reduction of 1.5-2.0% with weight loss benefits, as recommended by the American Association of Clinical Endocrinologists 1, 2

Daily fasting blood glucose monitoring is essential during the titration phase, with reassessments every 3 days during active titration, to ensure safe and effective insulin intensification 2, 3
Monitor for hypoglycemia, especially 2-4 hours after prandial insulin administration when insulin action peaks, and reduce the corresponding insulin dose by 10-20% immediately if hypoglycemia occurs 1, 2

With aggressive insulin titration and the addition of a GLP-1 receptor agonist, expect HbA1c reduction of 2.5-3.5% over 3-6 months, bringing the patient from 10.1% to approximately 6.5-7.5%, as predicted by the American Diabetes Association 1, 2